Our Leadership Team
BackReal-World & Late Phase
Colleen Coleman
Associate Director, Program Strategy
More From Our Expert
Consulting
How to Select Drugs to Switch from Rx to OTC
Before the 2012 Food and Drug Administration (FDA) Nonprescription Safe Use Regulatory Expansion (NSURE) initiative, sponsors were transitioning prescription drugs (Rx) to over-the-counter (OTC). Streamlined access to effective treatments clearly benefits patients and payers....
Real-World & Late Phase
Patient Enrollment and Retention: Overcoming Challenges in Observational Research
Patient enrollment and retention for investigational trials are notoriously difficult. How is enrollment affected when there is no direct benefit to the patient: no breakthrough study drug with the potential to cure, no added...